Cargando…
Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine
The parasite Plasmodium vivax is the most frequent cause of malaria outside of sub-Saharan Africa, but efforts to develop viable vaccines against P. vivax so far have been inadequate. We recently developed pathogen-mimicking polymeric vaccine nanoparticles composed of the FDA-approved biodegradable...
Autores principales: | Moon, James J., Suh, Heikyung, Polhemus, Mark E., Ockenhouse, Christian F., Yadava, Anjali, Irvine, Darrell J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273465/ https://www.ncbi.nlm.nih.gov/pubmed/22328935 http://dx.doi.org/10.1371/journal.pone.0031472 |
Ejemplares similares
-
The challenges of Plasmodium vivax human malaria infection models for vaccine development
por: Roobsoong, Wanlapa, et al.
Publicado: (2023) -
Antigen Delivery by Lipid-Enveloped PLGA Microparticle
Vaccines Mediated by in Situ Vesicle Shedding
por: Hanson, Melissa C., et al.
Publicado: (2014) -
Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivax
por: Yadava, Anjali, et al.
Publicado: (2017) -
Protective Efficacy of a Plasmodium vivax Circumsporozoite Protein-Based Vaccine in Aotus nancymaae Is Associated with Antibodies to the Repeat Region
por: Yadava, Anjali, et al.
Publicado: (2014) -
Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005)